Avego
Edit

Avego

https://avego.com
Last activity: 24.09.2024
Active
Invests in categories: MedtechBioTechDevelopmentHealthTechDrugResearchDiagnosticsLifePlatformTechnology
Avego is a multi-strategy investment firm specializing in healthcare. Our mission is to unite our industry expertise and capital with entrepreneurs and management teams to deliver successful results and improve the lives of patients.
News
15
Portfolio
17
Persons
8
Mentions
6
Employees: 11-50

Portfolio 17

DateNameWebsiteTotal RaisedLocation
10.11.2023Altoalto.com$500MUnited Sta...
22.06.2023Tourmaline...tourmalinebio.com$75MUnited Sta...
09.01.2023PBS Biotec...pbsbiotech.com$32M-
28.11.2022Escientescientpharma.com$237.5M-
-Sebela Pha...sebelapharma.com-United Sta...
-Health Out...healthoutlook.com$5.57MUnited Sta...
-Caribou Bi...cariboubio.com$655MAustralia,...
-AtomVieatomvie.com$90MCanada, On...
-Ribon Ther...ribontx.com$155MUnited Sta...
-Antios The...antiostherapeutics.com$196MSouth Afri...
Show more

Persons 8

DateFirst NameLast NameTitleLinkedInLocation
-LongYipAssociate-
-MorganBerkDirector o...-
-TomMarinoAssistant ...-
-ChristyKuo, PhDPrincipal-
-IvanMartinHead of Bu...-
-SteveJoSenior Ass...-
-AlyssaRomanoChief Fina...-
-EricPham, PhDManaging D...-

News 15

DateTitleDescription
01.06.2023AtomVie Global Radiopharma raises over $90M to Complete its New Facility BuildoutHAMILTON, ON /CNW/ – AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A financing led by its c...
27.03.2023Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan FacilityATLANTA (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision...
09.01.2023PBS Biotech Raises $22M to Expand Single-Use Manufacturing Products and Services for Cell Therapy ClientsCAMARILLO, Calif. /PRNewswire/ — PBS Biotech (“PBS”), an innovative, single-use bioreactor manufacturer and process development services provider, has completed a $22 million financing led by Avego Management, LLC (“Avego”) with additional ...
28.11.2022Escient Pharmaceuticals Announces $120 Million Series C FinancingSAN DIEGO–(BUSINESS WIRE)–Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the closing of a $1...
24.08.2022AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with AvegoHAMILTON ON /PRNewswire/ – AtomVie Global Radiopharma Inc. (“AtomVie”) today announced the successful closing of its Series A financing with Avego Management, LLC (“Avego”), a healthcare investment firm. AtomVie is a global leading CDMO (Co...
05.01.2022Amneal Acquires Saol Therapeutics’ Baclofen FranchiseBRIDGEWATER, N.J. & ROSWELL, Ga.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) and Saol Therapeutics, a private specialty pharmaceutical company (“Saol”), today announced a definitive agreement under which Amneal ...
07.12.2021Saol Therapeutics Announces FDA Approval of LYVISPAH™ (baclofen) Oral Granules and the Divesture of its Plasma-derived Hyperimmune PortfolioROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda /PRNewswire/ — Saol Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved Saol’s LYVISPAH™ (baclofen) oral granules.
10.11.2021Ellie Diagnostics Raises Growth Equity from Avego Healthcare CapitalDALLAS /PRNewswire/ — Ellie Diagnostics is pleased to announce a new capital partnership with Avego Healthcare Capital. Through this strategic investment, Avego will support Ellie in the expansion of its unique position as the leading indep...
03.11.2021Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBVMENDHAM, N.J. /PRNewswire/ — Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV), today announced the successful closing of a $75...
24.09.2021Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition CorporationREDWOOD CITY, Calif.–(BUSINESS WIRE)–Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the completion of its business combination with Amplitude Healthcare Acquisition Cor...
Show more

Mentions in press and media 6

DateTitleDescription
01.06.2023AtomVie Global Radiopharma raises over $90M to Complete its New Facility BuildoutHAMILTON, ON, June 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A ...
24.08.2022AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with AvegoHAMILTON ON, Aug. 24, 2022 /PRNewswire/ -- AtomVie Global Radiopharma Inc. ("AtomVie") today announced the successful closing of its Series A financing with Avego Management, LLC ("Avego"), a healthcare investment firm. ...
22.04.20134 apps to keep you green in more ways than one(MoneyWatch) Earth Day is a good reminder that we all can do things to improve the environment -- to be "green." And while being good to the place you call home is always a good idea, how much better is it to get two benefits for ...
26.07.2012Carpooling targets the U.S. market with investment from DaimlerBeing a backseat driver may no longer be a bad thing. Luxury car brand Daimler AG just invested an undisclosed amount in ride-sharing startup Carpooling. Although Munich, Germany-based Carpooling declined to specify the size of the investme...
26.07.2012Carpooling targets the U.S. market with investment from DaimlerWe are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Being a backseat driver may no longer be a bad th...
15.12.2010Avego Raises $5.6M in Series A Venture FundingAvego, a global provider of software and hardware for improving the efficiency of passenger transportation, raised $5.6m in a Series A venture capital funding. The round was led by SOSventures. Avego, which had previously raised $4.5m in se...

Reviews 0

Sign up to leave a review

Sign up Log In